» Articles » PMID: 32003403

No Difference in the Phenotypic Expression of Frailty Among Elderly Patients Recently Diagnosed with Cancer Vs Cancer Free Patients

Overview
Date 2020 Feb 1
PMID 32003403
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To examine frailty determinants differences in patients with a recent diagnosis of cancer compared to non-cancer patients among older adult. Revealing those differences will allow us to individualize the exact frailty management in those patients diagnosed with cancer.

Design: This is an observational cross-sectional, monocentric study.

Setting: Patients were evaluated at the Geriatric Frailty Clinic (GFC), in the Toulouse University Hospital, France, between October 2011 and February 2016.

Participants: 1996 patients aged 65 and older were included (1578 patients without cancer and 418 patients with solid and hematological cancer recently diagnosed).

Measurements: Frailty was established according to the frailty phenotype. The frailty phenotype measures five components of frailty: weight loss, exhaustion, low physical activity, weakness and slow gait. Frailty phenotype was categorized as robust, pre-frail and frail.

Results: In a multinomial logistic regression, cancer, compared to the non-cancer group, is not associated with an increased likelihood of being classified as pre frail (RRR 0.9, 95% CI [0.5 ; 1.6 ], p 0.9) or frail (RRR 1.2, 95% CI [0.7 ; 2.0], p 0.4) rather than robust. When considering each Fried criterion, a significant higher odd of weight loss was observed in older patients with cancer compared to the non-cancer patients (OR 2.3, 95% CI [1.8; 3.0], p <0.001) but no statistically significant differences was found among the four other Fried criteria. Sensitivity analysis on the frailty index showed that cancer was not associated with a higher FI score compared to non-cancer (β 0.002, 95%CI [-0.009; 0.01], p 0.6).

Conclusion: In this real-life study evaluating elderly patients with and without cancer, we didn't confirm our hypothesis, in fact we found that cancer was not associated with frailty severity using both a phenotypic model and a deficit accumulation approach. Cancer may contribute, at least additively, to the development of frailty, like any other comorbidity, rather than a global underlying condition of vulnerability.

Citing Articles

Frailty in chronic myeloid leukemia: evidence from 2016-2018 Nationwide Inpatient Sample of the US.

Huan-Tze L, Yun-Ru L, Kuan-Der L, Huey-En T BMC Geriatr. 2023; 23(1):334.

PMID: 37254068 PMC: 10228104. DOI: 10.1186/s12877-023-03962-7.


Cardiac Comorbidity Risk Score: Zero-Burden Machine Learning to Improve Prediction of Postoperative Major Adverse Cardiac Events in Hip and Knee Arthroplasty.

Onishchenko D, Rubin D, van Horne J, Ward R, Chattopadhyay I J Am Heart Assoc. 2022; 11(15):e023745.

PMID: 35904198 PMC: 9375497. DOI: 10.1161/JAHA.121.023745.


Neuropsychiatric Disorders and Frailty in Older Adults over the Spectrum of Cancer: A Narrative Review.

Muzyka M, Tagliafico L, Serafini G, Baiardini I, Braido F, Nencioni A Cancers (Basel). 2022; 14(1).

PMID: 35008421 PMC: 8796027. DOI: 10.3390/cancers14010258.

References
1.
Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

2.
Kirkhus L, Saltyte Benth J, Gronberg B, Hjermstad M, Rostoft S, Harneshaug M . Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study. Palliat Med. 2019; 33(3):312-322. PMC: 6376598. DOI: 10.1177/0269216319825972. View

3.
Katz S, Ford A, Moskowitz R, Jackson B, JAFFE M . STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA. 1963; 185:914-9. DOI: 10.1001/jama.1963.03060120024016. View

4.
Fried L, Ferrucci L, Darer J, Williamson J, Anderson G . Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004; 59(3):255-63. DOI: 10.1093/gerona/59.3.m255. View

5.
Handforth C, Clegg A, Young C, Simpkins S, Seymour M, Selby P . The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2014; 26(6):1091-1101. DOI: 10.1093/annonc/mdu540. View